Epigenetics refers to the study of heritable and dynamic molecular modifications that regulate gene expression without altering the underlying DNA nucleotide sequence. These modifications influence chromatin structure and transcriptional activity, thereby determining when, where, and to what extent genes are expressed.

Epigenetic profiling allows researchers and clinicians to better understand disease mechanisms at the molecular level. Because epigenetic changes can vary between individuals — even among those with similar genetic risk — they provide valuable insight for personalized treatment strategies.

Unlike permanent DNA mutations, epigenetic modifications are potentially reversible. This makes them promising therapeutic targets. Several emerging treatments aim to restore normal gene regulation patterns.

Epigenetics reshapes our understanding of health and disease. It demonstrates that biology is not determined solely by inherited genes, but by dynamic regulatory systems influenced by environment and experience.

Epigenetics

Brain Science

✳︎

Institute of Mental Health

✳︎

Institute of Psychiatry

✳︎

Commercial Design

Brain Science ✳︎ Institute of Mental Health ✳︎ Institute of Psychiatry ✳︎ Commercial Design

We study epigenetic processes—including DNA methylation, histone modifications, chromatin remodeling, and regulatory non-coding RNAs—that modulate gene expression in neural circuits implicated in psychiatric conditions. Particular emphasis is placed on how early life experiences, stress exposure, environmental factors, and neurodevelopmental timing shape long-term mental health outcomes via epigenetic pathways. Endpoint Research aims to:

  • Identify biomarkers for early detection

  • Stratify patients based on molecular signatures

  • Develop targeted epigenetic therapies

  • Understand treatment response variability